We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The role of fatty acid amide hydrolase enzyme inhibitors in Alzheimer's disease.
- Authors
Jain, Smita; Bisht, Akansha; Verma, Kanika; Negi, Swarnima; Paliwal, Sarvesh; Sharma, Swapnil
- Abstract
Fatty acid amide hydrolase (FAAH) is a prominent enzyme of the endocannabinoid system that degrades endogenous cannabinoid anandamide and oleamide. These lipid amides are involved in reducing neuroinflammation, pain and regulation of other neurological‐related activities including feeding behaviours, sleep patterns, body temperature, memory processes and locomotory activity. Many of these activities are affected in most neurological disorders. Increased levels of brain FAAH expressions are speculated to correlate with decreased levels of lipid amides and increased AD‐related symptoms. Thus, inhibition of FAAH shows promising potential in amelioration of symptoms associated with Alzheimer's disease (AD). The review aims at establishing the detrimental role of increased FAAH expression in AD and highlights the translational potential and therapeutic application of FAAH inhibitors in AD.
- Subjects
ALZHEIMER'S disease; FATTY acids; ENZYME inhibitors; BODY temperature; NEUROLOGICAL disorders; SYNTHETIC marijuana
- Publication
Cell Biochemistry & Function, 2022, Vol 40, Issue 2, p106
- ISSN
0263-6484
- Publication type
Article
- DOI
10.1002/cbf.3680